Get the Stockscreener App
10.96
0.27%
0.03
Benitec Biopharma Inc stock is traded at $10.96, with a volume of 71,260.
It is up +0.27% in the last 24 hours and down -9.50% over the past month.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
See More
Previous Close:
$10.93
Open:
$10.9
24h Volume:
71,260
Relative Volume:
0.65
Market Cap:
$287.71M
Revenue:
$59,000
Net Income/Loss:
$-21.81M
P/E Ratio:
-1.0007
EPS:
-10.9518
Net Cash Flow:
$-18.07M
1W Performance:
-1.97%
1M Performance:
-9.50%
6M Performance:
-4.61%
1Y Performance:
+30.01%
1-Day Range:
$10.53
$11.23
1-Week Range:
$10.53
$11.72
52-Week Range:
$7.05
$17.15
Benitec Biopharma Inc Stock (BNTC) Company Profile
Name
Benitec Biopharma Inc
Sector
Industry
Phone
(510) 780-0819
Address
3940 TRUST WAY, HAYWARD, CA
Compare BNTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNTC
Benitec Biopharma Inc
|
10.96 | 286.92M | 59,000 | -21.81M | -18.07M | -10.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Initiated | TD Cowen | Buy |
| Dec-16-24 | Initiated | H.C. Wainwright | Buy |
| Dec-13-24 | Initiated | Robert W. Baird | Outperform |
| Oct-16-24 | Initiated | Oppenheimer | Outperform |
| Sep-12-24 | Initiated | Guggenheim | Buy |
| Jul-22-24 | Initiated | Leerink Partners | Outperform |
| Jun-13-24 | Initiated | Piper Sandler | Overweight |
| Oct-05-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-20-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-26-16 | Downgrade | Maxim Group | Buy → Hold |
| Dec-31-15 | Reiterated | Maxim Group | Buy |
| Sep-16-15 | Reiterated | Maxim Group | Buy |
View All
Benitec Biopharma Inc Stock (BNTC) Latest News
How does Benitec Biopharma Inc. compare to its industry peersFree Stock Trend Scanner For 2025 - jammulinksnews.com
Can you recover from losses in Benitec Biopharma Inc.Controlled Entry Strategy With Safety Analytics - Newser
What is the dividend policy of Benitec Biopharma Inc. stockAdvanced Screener Report With High Returns - jammulinksnews.com
Visual trend scoring systems applied to Benitec Biopharma Inc.Portfolio Risk Distribution Analysis Tool - Newser
How Benitec Biopharma Inc. stock performs during market volatilityLong-Term Investment Strategy Impact Analysis - Newser
What is Benitec Biopharma Inc. company’s growth strategyReal Time Outlook With High Returns - jammulinksnews.com
Why Benitec Biopharma Inc. is moving todayTrade Safety Matrix for Conservative Traders - Newser
Will a bounce in Benitec Biopharma Inc. offer an exitMachine Learning Stock Movement Detector - Newser
Predicting Benitec Biopharma Inc. trend using moving averagesFree Oversold Bounce Stock Play Ideas - Newser
Does Benitec Biopharma Inc. fit your quant trading modelNeural Model for Stock Price Movement - Newser
What makes Benitec Biopharma Inc. stock price move sharplySafe Entry Zone Based on Chart Analysis - Newser
What is the risk reward ratio of investing in Benitec Biopharma Inc. stockBreakout Stocks Tracker With High Returns - jammulinksnews.com
Is Benitec Biopharma Inc. stock overvalued or undervaluedSwing Trade Tips For Consistent Profits - jammulinksnews.com
What are the technical indicators suggesting about Benitec Biopharma Inc.Advanced Screener Recommendation For 2025 - jammulinksnews.com
Does Benitec Biopharma Inc. stock pay reliable dividendsTrade Ideas Based on Fundamental Metrics - Newser
What to do if you’re stuck in Benitec Biopharma Inc.Smart Trade Mapping with Entry Details - Newser
New Product Launches: Will They Boost Benitec Biopharma Inc. Stock in 2025Multi-Year Investment Performance Summary Report - Newser
Benitec Biopharma Inc.’s Beta Climbs After Market VolatilityWeekly Chart Analysis With Entry Advice Provided - metal.it
Why Benitec Biopharma Inc. stock attracts strong analyst attentionMarket Stability and Long-Term Growth Outlook - Newser
Benitec Biopharma’s SWOT analysis: gene therapy stock shows promise amid clinical progress - Investing.com
How strong is Benitec Biopharma Inc. company’s balance sheetHigh-octane investment gains - jammulinksnews.com
Benitec Biopharma Inc. Moves Into Overbought Range Analysts CautiousRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Is it the right time to buy Benitec Biopharma Inc. stockAchieve consistent high returns with low risk - jammulinksnews.com
Should I hold or sell Benitec Biopharma Inc. stock in 2025Low Risk Alerts With Proven Results - jammulinksnews.com
What catalysts could drive Benitec Biopharma Inc. stock higher in 2025Achieve rapid portfolio growth with expert help - jammulinksnews.com
Intrinsic Value of Benitec Biopharma Inc. Stock: Is It Undervalued or Overvalued Dividend Strategy Summary With 10-Year Outlook - metal.it
How volatile is Benitec Biopharma Inc. stock compared to the marketSwing Trade Picks With Low Risk - jammulinksnews.com
Does Benitec Biopharma Inc. stock perform well during market downturnsCapitalize on momentum-driven investment opportunities - jammulinksnews.com
Is Benitec Biopharma Inc. a growth stock or a value stockBuild a winning investment strategy - jammulinksnews.com
Why is Benitec Biopharma Inc. stock attracting strong analyst attentionHigh-yield growth strategies - jammulinksnews.com
Benitec Biopharma Inc Stock (BNTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Benitec Biopharma Inc Stock (BNTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
| BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
| SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):